The document discusses several challenges related to pharmacovigilance when the same drug is marketed by different sponsors, such as generic manufacturers. It notes issues around aggregate safety reporting, signal detection, and obtaining safety data from other companies. The document also proposes "Safety in a Capsule" as a software solution that could help address these challenges by providing a unified platform for adverse event reporting, signal detection, and analytics across multiple drug manufacturers.
11. Unified Architecture for Drug Safety & Pharmacovigilance ADR submitted through Safety Manager ADR collected by the Call Centre Call Centre creates new ADR record which is pulled in by AE Rep System Unified Drug Safety and Pharmacovigilance environment AE Rep System and external DB for Signal detection, assessment & management AE Rep System generated reports for regulatory submission
21. Safety-in-a-Capsule TM - Solution Stack Services Processes Qualification & Validation Safety & Pharmacovogilance Implementation Configuration Administration Customization Production Support Technology Physical Security Data Security Data Privacy Business Continuity Information Security Monitoring Early warning Threshold triggers E-mail Alerts Signal detection Statistical Analysis Informed judgment Analysis Clinical Review, PA, Comparisons, Correlations, Drug-Drug Interaction Reporting SAE reporting PSUR, SUSAR, Periodic Oracle – AERS Oracle – TMS Oracle – Portal Siebel – Call Center DrugLogic – QSCAN Oracle – Business Intelligence Collection & Processing Maintain Database Data Collection (Call Center, Internet, e-Mail, Fax, etc.) Data Entry Medical coding Cleansing & Scrubbing Validation
Notes de l'éditeur
TCS Safety and Pharmacovigilance KPO Services is a modular stack which can be customized as per the needs of the Pharma companies existing drug safety environment. TCS provides a proven onsite-offshore model built on a secure platform and breadth of services addressing complete Safety and Pharmacovigilance processes.